MMTX — MindMaze Therapeutics Holding SA Share News
0.000.00%
Last trade - 00:00- CH₣34.12m
- CH₣24.65m
- CH₣0.64m
Swiss stocks - Factors to watch on November 30
Swiss stocks - Factors to watch on Nov 9
Swiss stocks - Factors to watch on November 5
Swiss stocks - Factors to watch on November 4
Brief: Acer Therapeutics And Relief Therapeutics Announce Issuance Of U.S. Patent 11,154,521 Covering ACER-001 Formulation
Brief: Relief Therapeutics And Acer Therapeutics Issue U.S. Patent 11,154,521 Covering ACER-001 Formulation
Swiss stocks - Factors to watch on Oct 15
Swiss stocks - Factors to watch on Oct 13
Brief: Acer Therapeutics Receives Notice Of Allowance Of Key U.S. Patent Application Covering Acer-001 Formulation
Brief: Acer Therapeutics And Relief Therapeutics Announce FDA Acceptance For NDA For Urea Cycle Disorders Treatment
Acer Therapeautics hits near 4-month high on FDA nod for new drug application
Brief: Relief Therapeutics And Acer Therapeutics Announce FDA Acceptance For Filing Of New Drug Application
Swiss stocks - Factors to watch on September 24
Swiss stocks - Factors to watch on September 13
Swiss stocks - Factors to watch on August 19
Brief: Acer Therapeutics And Relief Therapeutics Announce Submission Of A New Drug Application To The U.S. FDA For Acer-001 For Treatment Of Urea Cycle Disorders
Swiss stocks - Factors to watch on Aug 9
Brief: Relief And Acer Therapeutics Submit Of New Drug Application To FDA For Acer-001 For Treatment Of Urea Cycle Disorders
Brief: Relief To Buy All Outstanding Shares Of APR